Novocure (NVCR)
Develops wearable TTFields devices for brain, thoracic and pancreatic tumors.
$16.24
vs last close−0.43 (−2.57%)
Something off on this page? Send us feedback.
Next report
Oct 29, 26
in 36 days
EPS estimate
−$0.24
Revenue estimate
$182.3M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported−$0.61−$0.31−$0.36−$0.33−$0.22−$0.62−$0.13Pending
Estimate−$0.34−$0.47−$0.39−$0.42−$0.41−$0.51−$0.33−$0.24
Surprise−79.4%+34.0%+7.7%+21.4%+46.3%−21.0%+60.8%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Oct '26
Reported$161.3M$155.0M$158.8M$167.2M$174.4M$174.1M$183.6MPending
Estimate$147.6M$153.9M$158.8M$174.4M$174.4M$167.8M$172.4M$182.3M
Surprise+9.3%+0.7%0.0%−4.1%0.0%+3.7%+6.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.18 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.19 | — | — |
| Mar 2027 | −$0.22 | — | — |
| Dec 2026 | −$0.25 | — | — |
| Oct 2026 | −$0.24 | — | — |
| Jul 2026 | −$0.33 | −$0.13 | +60.8% |
| Apr 2026 | −$0.51 | −$0.62 | −21.0% |
| Feb 2026 | −$0.41 | −$0.22 | +46.3% |
| Oct 2025 | −$0.42 | −$0.33 | +21.4% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Oct 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Oct 2023 | |||
| Jul 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Oct 2022 | |||
| Jul 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Oct 2021 | |||
| Jul 2021 | |||
| Apr 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Jul 2020 | |||
| Apr 2020 | |||
| Feb 2020 | |||
| Oct 2019 | |||
| Jul 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Oct 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Jul 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Jul 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Oct 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.18 | — | — | $206.5M | — | — | — |
| Sep 2027 | −$0.19 | — | — | $199.8M | — | — | — |
| Jun 2027 | −$0.19 | — | — | $194.0M | — | — | — |
| Mar 2027 | −$0.22 | — | — | $188.1M | — | — | — |
| Dec 2026 | −$0.25 | — | — | $185.8M | — | — | — |
| Oct 29, 2026 | −$0.24 | — | — | $182.3M | — | — | — |
| Jul 23, 2026 | −$0.33 | −$0.13 | +60.8% | $172.4M | $183.6M | +6.5% | +28.4% |
| Apr 30, 2026 | −$0.51 | −$0.62 | −21.0% | $167.8M | $174.1M | +3.7% | +27.5% |
| Feb 26, 2026 | −$0.41 | −$0.22 | +46.3% | $174.4M | $174.4M | 0.0% | −8.3% |
| Oct 30, 2025 | −$0.42 | −$0.33 | +21.4% | $174.4M | $167.2M | −4.1% | −4.9% |
| Jul 24, 2025 | |||||||
| Apr 24, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Jul 25, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Oct 26, 2023 | |||||||
| Jul 27, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Oct 27, 2022 | |||||||
| Jul 28, 2022 | |||||||
| Apr 28, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Oct 28, 2021 | |||||||
| Jul 29, 2021 | |||||||
| Apr 29, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Jul 30, 2020 | |||||||
| Apr 30, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Oct 31, 2019 | |||||||
| Jul 25, 2019 | |||||||
| May 2, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Oct 25, 2018 | |||||||
| Jul 26, 2018 | |||||||
| Apr 26, 2018 | |||||||
| Feb 22, 2018 | |||||||
| Oct 26, 2017 | |||||||
| Jul 27, 2017 | |||||||
| Apr 27, 2017 | |||||||
| Feb 23, 2017 | |||||||
| Nov 2, 2016 | |||||||
| Jul 28, 2016 | |||||||
| May 9, 2016 | |||||||
| Feb 29, 2016 | |||||||
| Oct 26, 2015 | |||||||
| Oct 19, 2015 |